Skip to main content

Table 2 Characteristics and comorbidities of Hospitalized SSc patients with Pericardial effusion and cardiac tamponade

From: Pericardial effusions and cardiac tamponade in hospitalized systemic sclerosis patients: analysis of the national inpatient sample

  

Pericardial effusion (N = 15,303)

Cardiac Tamponade (N = 838)

N

%

N

%

P value

In hospital mortality

1268

8.30%

148

17.70%

< 0.0001

Sex

 

 Male

2310

15.10%

158

18.90%

 

 Female

12,993

84.90%

680

81.10%

 

Race

 

 White

7957

57.80%

422

54.80%

 

 Black

3459

25.10%

229

29.80%

 

 Hispanic

1616

11.70%

84

11.00%

 

 Asian or Pacific islander

303

2.20%

< 11

0.50%

 

 Native American

59

0.40%

< 11

0.60%

 

 Other

381

2.80%

25

3.30%

 

Pulmonary disease

6814

44.5%

305

36.3%

< 0.0001

Pulmonary circulatory disease

7851

51.30%

306

36.50%

< 0.0001

Alcohol use

158

1.00%

< 11

0.00%

0.003

Anemia

2745

17.00%

155

18.50%

0.678

Hypothyroidism

3264

20.20%

144

17.20%

0.021

Obesity

365

2.40%

30

3.60%

0.029

Smoking

1130

7.40%

59

7.00%

0.715

Prior CABG

55

0.4%

< 11

1.2%

< 0.0001

Congestive Heart failure

7118

46.50%

302

36.00%

< 0.0001

Atrial fibrillation

2932

19.20%

203

24.30%

< 0.0001

Coronary artery disease

2328

15.20%

138

16.50%

0.322

End stage renal disease

1010

6.60%

25

3.00%

< 0.0001

Hypertension

8430

55.10%

455

54.30%

0.667

Diabetes

260

1.70%

< 11

0.60%

0.015